RxDoctor Payments Data

Rachel Imperato

Nurse Practitioner · Osage Beach, MONPI 1801380845

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $221,840 of the $260,138 with a category attached, or 85.3%. Galderma Laboratories, L.p. accounts for 99.9% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2021 at $127,864 and has fallen 84.8% since, to $19,417 in 2025. Among nurse practitioner clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$260,138in general payments, 2019–2025

Across 443 payments — averaging $587.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Galderma Laboratories, L.p.$260K
  • Revance Therapeutics, Inc.$123
  • AbbVie$64

What the payments were for

  • Speaking & faculty fees$221,84085%
  • Travel & lodging$33,47013%
  • Food & beverage$4,8292%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Galderma Laboratories, L.p.441$259,952
Revance Therapeutics, Inc.1$123
AbbVie1$64

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$260,138 in reported general payments places this provider in the 95th percentile of 1,898 nurse practitioner providers in Missouri.

See all nurse practitioner providers in Missouri →

Other nurse practitioner in Osage Beach

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →